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Despite the steady increase in the number of studies focusing on the development of
tissue engineered constructs, solutions delivered to the clinic are still limited. Specifically,
the lack of mature and functional vasculature greatly limits the size and complexity of
vascular scaffold models. If tissue engineering aims to replace large portions of tissue
with the intention of repairing significant defects, a more thorough understanding of the
mechanisms and players regulating the angiogenic process is required in the field. This
review will present the current material and technological advancements addressing the
imperfect formation of mature blood vessels within tissue engineered structures.
Keywords: scaffolds, spatio-temporal gradient, vessel maturation, angiogenesis, tissue engineering
INTRODUCTION
The early promises of tissue engineering (TE) have been slow to materialize in recent years.
Despite numerous studies demonstrating the feasibility of tissue replacement with tissue engineered
constructs, clinical applications are scarce (Williams, 2019). It is interesting to note how the most
advanced solutions delivered to physicians are not conductive to vascularization (Fernandez de
Grado et al., 2018; Williams, 2019).
Indeed, it has quickly become evident that the diffusion of oxygen and supply of nutrients is
a major limit to the size and complexity of tissue engineered constructs, and that integrating a
network of blood vessels represents both a necessary and challenging step.
In order to reproduce the natural vascular structure in laboratory conditions, it is of paramount
importance to identify the molecular and cellular players, and their complex interactions, which
determine the success of the angiogenic process.
Angiogenesis, the formation of new blood vessels from existing ones, is relatively rare in adults
and almost entirely limited to areas of post-injury regeneration and tumor growth. These two types
of angiogenesis are driven by similar signals, however, deliver very different outcomes. Reparative
angiogenesis recreates functional and interconnected vessels, whilst tumor angiogenesis produces
a high number of immature and disorganized vessels (Ziyad and Iruela-Arispe, 2011; Viallard and
Larrivée, 2017).
Understanding the mechanisms regulating healthy and pathological angiogenesis should
therefore provide valuable clues to generate tissue engineered constructs embedded with robust
and mature vasculature.
During angiogenesis, quiescent endothelial cells (ECs) from an existing vessel are stimulated and
activated by the increase in concentration of pro-angiogenic factors produced by inflammatory or
tumor cells in response to injury and/or hypoxia. Activated cells proliferate and differentiate into
tip cells, leading to the elongation of new vessels toward the stimulus through active migration.
Stalk daughter cells ensure a continuum with the original vessel through regulated proliferation
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(Gerhardt et al., 2003; Carmeliet and Jain, 2011; Cathery
et al., 2018). Once the capillary is formed, ECs secrete
attractant molecules with the aim of recruiting perivascular
cells. Perivascular cells (pericytes in the capillaries and smooth
muscle cells in larger vessels) migrate along the newly
formed vessels to ensheath the endothelium, providing stability,
promoting cell differentiation, and regulating vessel permeability
(Cathery et al., 2018).
Some key features of this mechanism are: (i) temporal
regulation, (ii) spatial organization of the stimuli, (iii) cellular
crosstalk, (iv) active remodeling and interaction with the
extracellular matrix (ECM). When any of these features are
dysregulated, the development of new vasculature is abnormal,
such as in the case of tumor angiogenesis (Ziyad and Iruela-
Arispe, 2011). Cancer associated vessels present excessive
tortuosity, larger lumens, hyperpermeability and uncontrolled
sprouting (Ziyad and Iruela-Arispe, 2011). These aberrant
features are often the result of the disruption of the tightly
regulated sequence of stimuli necessary to deliver healthy
angiogenesis, such as the excessive or sustained release of
proangiogenic factors. Similarly, angiogenesis within tissue
engineered scaffolds is traditionally stimulated by the addition
of single growth factors (GF) to the whole construct, leading
to poorly organized and immature blood vessels, reminiscent of
tumoral angiogenesis.
Therefore, this review summarizes state of the art material
and TE solutions devised to overcome these current limitations,
and attempts to provide new avenues to ensure the formation
of mature and hierarchically organized vasculature within tissue
engineered constructs.
TEMPORAL CONTROL OF
ANGIOGENESIS
Angiogenesis is a dynamic process where a series of events
progress following a precisely timed schedule (Bentley and
Chakravartula, 2017). At the single cell level, mechanical
and chemical sensing drive the internal signaling response
and consequent actions (proliferation, migration, and
differentiation). Therefore, temporal delivery of bioactive
molecules in a tissue engineered scaffold is key to the
development of structured blood vessels.
Most commonly, GF and other molecules are incorporated
into TE scaffolds by non-covalent adsorption in the scaffold
material (King and Krebsbach, 2012). In this way, growth factor
release is based on the affinity of the molecules with the scaffold
material, or through controlling the kinetics of molecule diffusion
(Whitaker et al., 2001). While not a time-controlled system, this
method allows simple control of both abundance and diffusion
of a single compound (or several compounds with different
chemical affinities) released from the scaffold (Nguyen et al.,
2013). This method is often used when scaffolds are employed
as delivery systems for the controlled release of molecules to
organs or tissues.
When the focus is instead on the delivery of molecules to
cells seeded directly on the scaffold, the simplest approach is the
progressive addition of molecules over time to cells in culture
prior to seeding, as discussed in section “Differentiation in vitro
(Progressive Addition of Growth Factors)”. More advanced
systems have been developed using cleavable linkers and modified
scaffolds to induce timed released of GF, facilitating potential
use in vivo. Crucially, despite the novelty of the various delivery
systems developed, the variety of molecules used to stimulate the
angiogenic process remain limited (Table 1).
In this section, we will review the recent advances in
temporally controlled release of GF in scaffolds, with a focus on
the signal triggering the release of bioactive molecules.
Differentiation in vitro (Progressive
Addition of Growth Factors)
The most effective way to guide cell differentiation is to load
bioactive molecules onto the biomaterial initially. This has been
achieved by sequential or simultaneous delivery of multiple GF
to pre-seeded scaffolds, leading to improved neovascularization
before implantation (Tengood et al., 2011). Brudno et al. (2013)
stated that the combination of VEGF and Ang2, followed by
sequential addition of PDGF and/or Ang1, promoted vascular
maturation in vitro.
However, the sequential delivery of biomolecules has several
disadvantages: (i) short half-life and rapid degradation in vivo; (ii)
uncontrollable pharmacokinetics; (iii) risk of delivering supra-
physiological doses.
Degradation Dependent Release
During sprouting, ECs produce and secrete several proteolytic
enzymes which escape the ECM and migrate (Rundhaug, 2005).
These enzymes are naturally able to degrade ECM-derived
scaffolds used for TE, and therefore natural polymer-based
scaffolds are often preferred because of their biocompatibility
and biodegradation following implantation (Asghari et al., 2017).
The release of molecules from the scaffold can be controlled
by modifying the properties and composition of the material,
TABLE 1 | List of common bioactive molecules used in tissue engineering
vascularization and mentioned in this review.
Bioactive molecule References
VEGF Lee et al., 2001; Gerhardt et al., 2003; Chiu and
Radisic, 2010; Chow et al., 2010; Yuen et al., 2010;
Shah et al., 2011; Zheng et al., 2012; Brudno et al.,
2013; Nguyen et al., 2013; Alsop et al., 2014; Lai
et al., 2014; Rich et al., 2014; Stamati et al., 2014;
Wu et al., 2016; LaValley et al., 2017; Turner et al.,
2017; Kuttappan et al., 2018; Stejskalová et al.,
2019; Wang et al., 2019
FGF Chow et al., 2010; Tengood et al., 2011; Lai et al.,
2014; Stamati et al., 2014; Kuttappan et al., 2018;
Dong et al., 2019
IGF Holland et al., 2005
EGF Lai et al., 2014
PDGF Tengood et al., 2011; Brudno et al., 2013; Lai et al.,
2014; Stejskalová et al., 2019; Wang et al., 2019
Glycosaminoglycans Chow et al., 2010; Chow et al., 2014; Wu et al.,
2016
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as well as changing the method of retaining the drug (King
and Krebsbach, 2012). Boontheekul et al. (2005) modified
alginate gels, which are naturally susceptible to hydrolysis, with
partial oxidation and controlled molecular weight to obtain
a tunable degradation rate. Holland et al. (2005) created a
system for double delivery of insulin like growth factor-1
(IGF-1) and transforming growth factor beta-1 (TGFβ-1) using
oligo(poly(ethylene glycol) fumarate) (OPF) hydrogel phase and
gelatin microcarriers. By controlling the degradation of the
hydrogel and the microcarrier, it was possible to optimize the
kinetics of the GF release (Holland et al., 2005). Similarly,
Shah et al. (2011) used polyelectrolyte layers to encapsulate
recombinant human bone morphogenetic protein-2 (rhBMP-
2) and recombinant human vascular endothelial growth factor
(rhVEGF), and showed controlled release of the encapsulated
factors over time both in vitro and in vivo. Furthermore,
Kuttappan et al. (2018) recently demonstrated the benefit of
differential release by functionalizing a nanocomposite fibrous
scaffold with combinations of VEGF, fibroblast growth factor
(FGF) and BMP2. The release of these factors at different times
led to increased tissue vascularization and bone regeneration
(Kuttappan et al., 2018). Degradation-dependent release is based
on the non-covalent adsorption of the molecules on the scaffold,
and as such is susceptible to a high release of factors immediately
after contact with physiological fluids, a phenomenon termed
burst release (Huang and Brazel, 2001). Burst release leads to
the quick loss of high concentrations of adsorbed molecules,
delivering an unwanted concentration spike to the cells. Over
the last decade, researchers have developed solutions to limit this
phenomenon. For instance, increasing the cross-linking density
of gelatin can improve molecule retention and limit its diffusion
(Iwanaga et al., 2003; Patel et al., 2008). Turner et al. (2017)
crosslinked gelatin microspheres to drive a more regulated release
of VEGF or BMP2, dependent on the progressive proteolytic
degradation of the scaffold. The non-specific degradation of the
scaffold only partially controls the delivery time of GF, making
it necessary to develop more advanced systems, which will be
discussed later.
Trigger Specific Release of Bioactive
Molecules
Sequential delivery of GF from scaffold can be obtained by
incorporation of different molecules in sequential layers of
polymers, a technique termed layer-by-layer (LBL) (Rouwkema
and Khademhosseini, 2016). By incorporating different biomole-
cules in different layers and taking advantage of matrix-degrading
enzymes produced by cells, it is possible to deliver GF sequentially.
One interesting example is a LBL polycaprolactone (PCL) scaffold
built with layers enriched with heparin and VEGF, intended
for vascular grafts applications. The authors reported an initial
burst release of VEGF, triggered by the ECM degrading enzyme
metallopeptidase-2 (MMP-2), followed by a controlled release
of heparin with an anti-thrombogenic effect on long term
vascularization of the engineered graft (Wang et al., 2019).
Advanced methods rely on the use of an enzyme sensitive
linker binding the pro-angiogenic molecule covalently to the
scaffold. Targeting the linker sequence to a specific enzyme (e.g.,
metalloproteinases, serine or cysteine proteinases) determines
timely release as these enzymes are produced by cells at
specific times during differentiation or angiogenesis (Fonseca
et al., 2014). Alternatively, light-sensitive linkers can be used
to covalently bind the molecule of interest to the scaffold,
with UV or near infrared (NIR) light used to release “caged”
biomolecules (Linsley and Wu, 2017; Ruskowitz and DeForest,
2018). However, the next challenge for regenerative medicine
is to develop a wavelength specific photocleavable release of
factors for optimal on-demand delivery of GF. Azagarsamy and
Anseth (2013) tested this method by covalently binding BMP-
2 and BMP-7 to a scaffold using nitrobenzyl- and coumarin-
based azides linkers, respectively. The hydrogels were then seeded
with human mesenchymal stem cells (hMSC), and different
wavelengths of light, 365 and 405 nm, were applied to induce the
sequential release of molecules, resulting in improved osteogenic
differentiation in vitro.
A further strategy to control the release of bioactive
molecules is encapsulation. Encapsulation also provides a layer
of protection for GF, increasing their short half-life. Minardi
et al. (2014) used this technique to design a scaffold patterned
with composite microspheres, enabling spatiotemporal release of
proteins. Furthermore, Lai et al. (2014) used encapsulation via
nanofibers and gelatin nanoparticles to create a scaffold capable
of a stagewise release pattern of VEGF, PDGF, FGF, and EGF
(epithelial growth factor). The gradual release of these factors was
sustained for over a month, and resulted in increased endothelial
cell proliferation and development of vascular-like structures.
These novel methods offer the advantage of a trigger to control
GF delivery, imitating the temporal pattern observed in natural
angiogenesis, albeit with a still limited complexity.
Mechanical Release
An alternative trigger to release GF from the scaffold is mechanic
stimulation, by which cells applying traction forces can deform
the scaffold at the microscopic level, liberating the entrapped
molecules. A simple application of this consists of incorporating
a drug into an alginate gel and allowing the cells to apply pressure
on the matrix, stimulating molecule release (Lee et al., 2001).
Stejskalová et al. (2019) developed a method that uses cell-specific
traction forces to trigger GF release from a biomaterial construct.
The technology relies on the use of Traction Force-Activated
Payloads (TrAP) composed by aptamers (short, single-stranded
oligonucleotides that fold into 3D structures) flanked by a cell-
adhesive peptide. The aptamers trap the GF in their 3D structure,
whilst the peptide is able to bind the cell surface; the whole
group is anchored to the scaffold by a linker. When the cells bind
to the cell-adhesive peptide and pull the scaffold structure, the
cellular traction force acts as a biophysical trigger to unfold the
aptamer and release/activate the GF. Importantly, delivery can be
made cell-specific by selecting a peptide which binds to a cell-
specific receptor. This method has been tested with VEGF on
human microvascular endothelial cells (HMEC-1) and PDGF-
BB on primary human dermal fibroblasts (HDFs), resulting in
a remarkable increase in the proliferation rate for both cell
types. Interestingly, TrAP allows the release of the payload
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in a temporal manner which is dependent on the expression
of the cell surface receptor targeted by the adhesive peptide
(Stejskalová et al., 2019).
Acoustic waves can be used to release molecules from
acoustically responsive scaffolds (ARSs) (Dong et al., 2019).
Dong et al. developed a bFGF functionalized ARS that released
GFs upon ultrasound-mediated triggering of acoustic droplet
vaporization. The authors did not observe an effect on the
angiogenic sprouting following the temporal release, but the
technique itself has great potential for future in vitro and
in vivo applications.
SPATIAL CONTROL OF ANGIOGENESIS
In this review, we have so far discussed the temporal regulation of
growth factor release during angiogenesis. However, angiogenesis
in vivo is also tightly regulated via spatial cues that direct
vessel sprouting and maturation. Stimuli such as ischemia or
inflammation, provoke a localized release of GF, cytokines and
chemokines, which effectively creates a gradient within the
extracellular space (Carmeliet, 2000). The establishment of this
molecular gradient leads to the formation of a spatially controlled
leading edge of cells, which induces localized angiogenesis and
increased perfusion. Current TE practices have attempted to
mimic this process using simplified systems with varying degrees
of success. The primary methods to obtain spatial control rely
on either the direct patterning of the cells through bioprinting,
or on the organized distribution of the molecules providing the
pro-angiogenic stimulus.
Here, we highlight the most promising techniques and recent
advancements in the field. We have limited the discussion to
spatial organization of scaffolds and not the types of biomaterials
used, which presents another significant consideration outside
the scope of this review.
Spatial Control of the Scaffold
Architecture and Cell Organization
3D Bioprinting
Three-dimensional (3D) printing has been applied extensively
in the field of regenerative medicine to promote angiogenesis in
engineered tissues. Through direct or indirect printing methods,
cells, biomaterials, and GF can be combined to produce complex
shaped constructs with defined micron-sized channels and pore
sizes that are capable of guiding angiogenesis.
Direct bioprinting involves active printing of bio-ink droplets,
containing cellular and extracellular components, into defined
shapes. This approach requires a stringent cross-linking process,
or rapid gelation of hydrogels, to produce a stable structure.
On the other hand, indirect bioprinting is based on printing a
sacrificial frame or channels that are then encapsulated by the
cell-loaded biomaterial. These frames or channels can later be
removed using thermal modifications or a suitable solvent to
leave a capillary-like network, which after seeding with ECs, is
used to guide angiogenesis (Sarker et al., 2018).
Inkjet bioprinting is a method of direct 3D printing which
involves the LBL dispersion of bio-ink droplets onto a substrate
using a thermal or piezoelectric actuator. It utilizes cross-linking
agents combined with hydrogels that possess rapid gelation
properties to print highly organized networks. For example, using
computer aided design, alginate-based bio-inks can be printed
into a calcium chloride solution where they rapidly gelate. This
technique has been used to create 200 µm diameter vessels
(Nishiyama et al., 2009). Furthermore, Cui and Boland (2009)
demonstrated the relative ease of modifying a standard thermal
inkjet printer to simultaneously print an endothelial cell and
fibrin-based microvasculature. The ECs aligned and proliferated
within the printed channels to form a confluent lumen-like
structure (Cui and Boland, 2009). Overall, this method is
inexpensive due to the ability to adapt regular printers and allows
for deposition of multiple cell types. Critically, however, the stress
exerted on cells during extrusion can cause apoptosis and uneven
dispersion, limiting its applicability.
Extrusion or pressure assisted bioprinting is one of the most
common methods used to promote angiogenesis and vasculature
formation (Miri et al., 2019). This technique is similar to inkjet,
however, the bio-ink is deposited using a pressure-based system
rather than a thermal or piezoelectric actuator. It has been utilized
by various research groups to directly fabricate vascular-like
networks (Zhang et al., 2013; Jia et al., 2016). For example, using
the direct methodology, Jia et al. (2016) utilized an advanced
extrusion system and bio-ink blend to fabricate highly organized
cell-loaded perfusable vascular structures. The coaxial nozzle
system was capable of producing tubes with a wide range of
diameters (500–1500 µm) and wall thicknesses (60–280 µm).
In combination with bio ink containing encapsulated vascular
cells, this method could induce formation of functional vessels
(Jia et al., 2016).
Lately, focus has shifted toward the use of indirect bioprinting
due to the higher level of precision and wider array of
biomaterials that can be utilized. For example, Miller et al.
(2012) printed a 3D filament network of carbohydrate glass
and embedded it in a hydrogel. The filament network was
then sacrificed to create a cylindrical network with controlled
geometry which could then be seeded with ECs (Miller et al.,
2012). Kolesky et al. (2014) used a similar sacrificial approach
using a fugitive bio-ink composed of Pluronic F127 mixed
with cell laden Gelatin-Methacryloyl (GelMA) to create a vessel
matrix. This was then encased in a GelMA hydrogel and
the bio-ink removed by liquifying, leaving a lumen which
was then functionalized by seeding with ECs (Kolesky et al.,
2014). More recently they have built upon this technique to
produce vascularized tissues >1 cm in thickness with long
term survival (Kolesky et al., 2016). This demonstrates the
potential of 3D bioprinting for creating physiologically relevant
vascularized tissues.
Laser-based bioprinting is a less common form of bioprinting
and is performed via either photopolymerisation or laser-induced
forward transfer (Sasmal et al., 2018). Although expensive, this
technique can print cells at a very high resolution without
subjecting them to shear stress (Kant and Coulombe, 2018).
Wu and Ringeisen (2010) demonstrated the feasibility of
this approach by using biological laser printing (BioLP) to
fabricate human umbilical vein endothelial cell (HUVEC) and
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smooth muscle cell (SMC) branch structures with interconnected
lumens. Furthermore, Jia et al. (2016) recently utilized a
photopolymerisation-based 3D bioprinting system to create a
complex pre-vascularized tissue. Assessment of the tissue 2-
weeks post implantation revealed successful anastomosis between
tissue and host vasculature. In addition, a significant increase
in vascular density and number of vessels was observed in the
pre-vascularized tissue, as compared to the control.
Bioprinting is an exciting field that holds great potential
for delivering controlled angiogenesis. Studies have already
demonstrated success in promoting vascularization in
engineered tissues with increasing scales. With advancements
in printing technologies to increase precision of printing, and
the development of less expensive techniques, there is no doubt
that we will see printable pre-vascularized whole tissues in
the years to come.
Electrospinning
In recent years, researchers have explored the possibility of using
electrospinning techniques to produce nanofiber-based vascular
networks. This fabrication technique allows for fine control over
properties such as diameter, porosity and degradation rate. In
addition, fibers produced using this method possess a similar
diameter to natural ECM (50–500 nm) and therefore mimic
natural topographical cues (Jundziłł et al., 2017). Kenar et al.
(2019) created a micro-fibrous composite scaffold using poly(L-
lactide-co-ε-caprolactone) (PCL) blended with collagen and
hyaluronic acid that greatly enhanced the length of vasculature in
engineered tissues. Furthermore, Cui et al. (2017) demonstrated
improved pre-vascularization of constructs by seeding HUVEC
on LBL aligned (PCL)/cellulose nanofiber matrices. Once
implanted, the aligned fiber matrices promoted integration with
the host vasculature. Other groups have used the nanoscale
properties of electrospinning to produce matrices capable of
mimicking bone ECM and significantly enhancing in vivo
angiogenesis via spatial organization of fibers (Gao et al., 2017),
further highlighting the potential as a vascularization strategy.
Patterning of Bioactive Molecules
The biofabrication methods described above can be also
employed to pattern bioactive molecules within scaffolds, in an
attempt to emulate biochemical gradients, present in natural
angiogenesis, and promote in situ vascularization via integration
with the host vascular network.
Due to its potent effect on angiogenesis, VEGF is the most
commonly used growth factor for patterning of scaffolds. For
example, Alsop et al. (2014) used photolithography to print
VEGF onto a collagen-glycosaminoglycan scaffold in a spatially
defined manner. They reported greater cell infiltration into the
scaffold and presence of immature vascular networks. Similarly,
hydrogels have been designed that induce directional vessel
growth via pre-defined release of VEGF (Rich et al., 2014).
The requirement for precise spatial control is demonstrated
by the observation that promotion of aligned vasculature was
only detected when the hydrogel was printed parallel to existing
vasculature, but not when oriented perpendicularly.
In addition to spatially defined GF deposition, some
researchers have incorporated combinations of different GF
into the scaffold material to better replicate the different
stages of angiogenesis (Rouwkema and Khademhosseini, 2016).
Improved angiogenesis and maturation of the construct has been
reported both with a combination of VEGF, FGF, and BMP2
(Kuttappan et al., 2018), and with VEGF and Angiopoietin
(Chiu and Radisic, 2010).
Even with the use of multiple GF, these systems are still
relatively basic in comparison to the complexity of native
angiogenesis. The simple incorporation of bioactive molecules
in the scaffold material does not sufficiently ensure its spatial
localization, due to diffusion and burst release (Rouwkema and
Khademhosseini, 2016; Kant and Coulombe, 2018). In order to
address these challenges, various techniques have been employed.
Wu et al. (2016) functionalized decellularised scaffolds with
heparin via end point attachment. This enabled the scaffolds to
bind and release heparin-binding GF, such as VEGF, with an
increased level of control, resulting in enhanced angiogenesis.
Another group printed a biodegradable polymer scaffold with
conflicting zones of VEGF and VEGF inhibitors to spatially
restrict signaling (Yuen et al., 2010).
In addition to GF, peptides have been used to functionalize
scaffolds and induce vessel formation. These peptides can
incorporate angiogenic domains whilst possessing a greater
stability than GF (Fu and Wang, 2018). For example, Shu et al.
(2015) demonstrated that functionalization of hydrogels with
RoY, a 12 amino acid synthetic peptide, increased tube formation
in vivo compared to the non-functionalized scaffold. Similarly,
incorporation of peptide motives KLT and PRG into peptide
nanofiber scaffolds resulted in a positive effect on endothelial cell
viability and proliferation (Wang et al., 2011). Interestingly, Lei
et al. (2012) used photolithography to micropattern SVVYGLR
peptide strips on polymer surfaces. ECs seeded onto 10 and
50 µm peptide strips were directionally regulated and underwent
morphogenesis, forming tubular structures with a central lumen.
Conversely, tube formation was not observed in larger, 100 µm
strips. This underlines the importance of spatial organization in
vascularization strategies.
Many other peptide sequences have also been used to
improve adhesion of ECs, which in turn encourages vessel
development (West and Moon, 2008). Importantly, peptides
are very easily patterned on to surfaces and scaffolds by
covalent binding to the scaffold material, and are relatively
resilient to processing. These characteristics have been harnessed
for vascular TE by electrospinning two differently peptide-
conjugated PCL solutions. The produced scaffold presented
spatially organized functionalities, the SVVYGLR EC adhesion
peptide and a heparin-binding peptide, and displayed improved
endothelialisation (Campagnolo et al., 2016). Similarly,
Chow et al. (2014) utilized peptide-PCL conjugates with a
specific affinity for glycosaminoglycans (GAGs), combined
with sequential electrospinning techniques, to guide spatial
organization of GAGs throughout a scaffold. Using this method,
rather than covalent bonding, preserves the bioactivity of the
GAGs, mimicking the natural ECM and providing a more
clinically relevant tissue construct. Both the heparin-binding
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 5 March 2020 | Volume 8 | Article 188
fbioe-08-00188 March 19, 2020 Time: 17:11 # 6
Mastrullo et al. Angiogenesis in Tissue Engineering
peptide and the GAG gradient within the scaffolds help to
organize growth factor and cytokine distribution, promoting cell
infiltration and direction of biological processes.
Patterning of biomolecules shows great promise for
promoting vascularization in engineered scaffolds and tissues.
Researchers have begun to address initial limitations, such as
random distribution of GF, by encapsulating biomolecules before
patterning of scaffolds. There is still a long way to go before true
chemotactic gradients representative of the in vivo angiogenic
environment can be realized. Technologies such as nanoparticles,
which provide a greater level of control for biomolecule
patterning and release, offer great hope for the future.
INTERACTION WITH THE ECM
The microenvironment represents a fundamental regulatory
system for angiogenesis, and the analysis of cell-ECM interactions
is an important area for TE research.
The main challenge for TE is to develop a biologically inspired
scaffold to mimic the natural ECM. For this purpose, natural
polymers, such as hydrogels, represent the preferred choice
because of their biomimetic potential (Fonseca et al., 2014).
However, reproducing the complexity of the matrix is not easy
and a series of factors must be considered; such as mechanical
properties, cell adhesion and incorporation of GF.
MECHANICAL PROPERTIES OF THE
SCAFFOLD
The mechanical properties of scaffolds, i.e., stiffness, porosity,
shear stress, hydrophobicity, and internal architecture
(alignment), have been shown to affect cellular behavior
in vitro. ECs are capable of modulating their behavior in response
to alterations in substrate stiffness. For example, HUVECs can
increase their expression of MMPs, such as MMP2, MMP3,
MMP4, and MMP14, and of angiogenic GF, such as VEGFA,
when co-cultured in vitro with adenocarcinoma cells on stiff
polydimethylsiloxane (PDMS) substrates, whilst MMPs are
downregulated with decreased stiffness (Zhao et al., 2018).
Increased stiffness of polyacrylamide (PA) scaffolds from 1 to
10 kPa has been shown to boost the endothelial cell response to
VEGF by increasing VEGFR-2 internalisation (LaValley et al.,
2017). Similarly, increased stiffness of collagen coated PA gels in
a range from 3 to 3,000 Pa affected the expression of functional
proteins and GF in HUVECs, but did not affect their proliferation
and gene expression (Santos et al., 2015). Differentiation of
endothelial progenitor cells was proportional to the stiffness of
the PDMS scaffolds (Xue et al., 2017). Despite advancements in
unveiling the cell-sensing of stiffness, the molecular signaling
remains unclear. Furthermore, during migration and sprouting,
cells can experience different stiffnesses, which is also dependent
on the tissue type (Singh et al., 2018).
The porosity level, pore size and pore interconnectivity
of a scaffold all affect cell behavior considerably
(Loh and Choong, 2013; Bružauskaitë et al., 2016). For example,
a pore size increase (to >40 µm) in PCL scaffolds was shown
to enhance colonization and tube formation of endothelial
progenitor cells (Hong et al., 2015). Likewise, cardiomyocytes
demonstrated increased survival, enhanced angiogenesis and
reduced fibrotic reaction in poly(2-hydroxyethyl methacrylate-
co-methacrylic acid) hydrogel scaffolds of 80 and 40 µm
pore size, as compared to 20 µm and non-porous constructs
(Madden et al., 2010). In general, a minimum overall porosity
of approximately 50%, along with a pore size of approximately
35–100 µm, is considered optimal for blood vessel formation
(Oliviero et al., 2012). Mathematical simulations enable a more
accurate design and prediction of the optimal pore size for
maximizing homogenous cell distribution and cell proliferation
within a specific scaffold (Mehdizadeh et al., 2013).
Furthermore, the scaffolds’ surface topography and
physical/chemical properties can affect cell behavior. For
example, changes in wettability and electric charges can affect
cell adhesion on a biomaterial surface (Guo et al., 2016). From a
topographical point of view, the roughness, i.e., nano-roughness
(<100 nm), micro-roughness (100 nm–100 µm), and macro-
roughness (100 µm–1 mm), and curvature of a surface can affect
cell proliferation, spreading and metabolic activity (Ferrari et al.,
2019). Roughness of scaffolds at the nano-range have shown
to improve the growth of ECs on poly-urethane-poly(ethylene
glycol) surfaces (Chung et al., 2003).
Overall, whilst the above mechanical properties have been
proven to affect cell behavior and angiogenesis in vitro, the
exact biological mechanisms of action remain unexplored.
Furthermore, different studies are conducted on biomaterials
of different properties and are limited to a single parameter
variation, ignoring the great challenge represented by the
interdependency of these parameters. For example, altering
the porosity of a material alters its stiffness, and for this
reason disentangling the individual effects from altering single
mechanical parameters/factors is hugely complicated (Chim
and Mikos, 2018). Overall, systematic studies altering multiple
mechanical properties on several materials are still needed to
robustly unravel the impact on angiogenic cell behavior.
Promotion of Cell Adhesion
Attachment of cells to a scaffold, followed by migration in the
pores and proliferation, is necessary for the correct development
of a 3D structure. The cell-ECM interaction is mediated by
transmembrane proteins, such as integrins, exposed on the
cell surface (Post et al., 2019). Their key role is to initiate
an intracellular signaling cascade that induces the cell to
attach, migrate or differentiate (Ivaska and Heino, 2000). Many
strategies have been used to facilitate this process by coating the
scaffolds with proteins like collagen, laminin, and fibronectin
(Post et al., 2019). Stamati et al. (2014) demonstrated that by
coating a collagen I hydrogel with laminin, EC aggregation
patterns can be regulated (Stamati et al., 2014). In the
presence of laminin, EC formed an end to end network with
increased integrin α6 expression and VEGF uptake. However,
in absence of laminin EC formed cobblestone-like sheets and
slowed VEGF uptake (Stamati et al., 2014). Importantly, by
changing the chemistry, density and composition of peptides
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on the backbone, it is possible to control the stiffness of
the biomaterial independently from the scaffold architecture
(Spicer, 2020).
Covalent immobilization of peptides/proteins on the surface
of scaffolds can be used as an alternative to coating, improving
the stability of biomolecules (Zhu and Clark, 2014) and
allowing the selection of cell-specific sequences to target the
desirable cells on the scaffold (Uchida et al., 2007). John et al.
(2019) fabricated a GelMA nanofiber microsphere coated with
VEGF-mimic peptides, and showed the formation of vascular
tubes by HUVEC. Similarly, Flora et al. (2019) demonstrated
that elastin-like recombinamer (ELR) tethered with VEGF-
mimic peptides not only improved vascularization in vitro,
but also in vivo. In fact, ELR injected into mice enhanced
the recruitment and proliferation of ECs, and the number of
capillaries (Flora et al., 2019).
Presentation of Growth Factors
Soluble GF often contain sequences targeting the ECM, which
in vivo allows the correct presentation of the GF and provides
the spatio-temporal definition to the gradient. When designing
a 3D matrix, the simplest way to incorporate GFs is to
encapsulate them during gelation or solidification (Wang et al.,
2017b). However, in order to improve the exposure of the
GF on the fibrils, effective results are obtained using self-
assembling peptides (King and Krebsbach, 2012). Rajangam et al.
(2006) used heparin-binding peptide amphiphile nanostructures
containing heparin binding sites for GF like VEGF and FGF-
2. Interestingly, the rigidity of the scaffold allows the GF to
expose the bioactive domains, minimizing Brownian motions
and promoting cell attachment and receptor binding (Rajangam
et al., 2006). Similarly, Chow et al. (2010) used nanoscale fibers
to deliver VEGF and FGF-2 to pancreatic islets, enhancing
the bioactivity of the GF, promoting the angiogenic sprouting
and increasing islet survival, providing new insights into
in vivo therapeutic applications. In addition to engineering
the scaffold, the affinity of vascular GF to the ECM can
be improved by means of protein engineering. An example
of this is the fusion of the strong ECM-binding domain
of the placenta growth factor-2 protein, which was shown
to enhance the repair of chronic wounds and bone defects
(Martino et al., 2014).
OTHER MECHANISMS
Effect of Circadian Clocks
Circadian rhythms modulate many physiological processes and
are essential for the maintenance of homeostasis within a tissue.
The clock machinery has been identified in vascular cells (Nonaka
et al., 2001; Takeda et al., 2007), bringing attention to the effect
of the circadian clock in vascular formation and remodeling.
Particularly, the peripheral circadian clock in the vasculature
influences the formation of new blood vessels in vivo (Jensen
et al., 2014). A disrupted circadian clock leads to pathological,
uncontrolled angiogenesis (Anea et al., 2009; Jensen et al., 2014;
Block, 2018). Moreover, the effect of circadian clocks on the
cell specific response to micro-environmental changes has been
examined. Interestingly, in the context of TE, circadian rhythms
appear to be mechano-sensitive (Streuli and Meng, 2019). The
structure and stiffness of the tissues, as well as the composition
of the ECM, affects circadian output and appears to be cell-
specific (Yang et al., 2017; Broadberry et al., 2018; Williams
et al., 2018). This area still requires extensive research but, in
the future, may develop new evidence toward circadian control
of angiogenesis in cancer and wound healing. For a complete
overview of the subject, we recommend the recently published
article by Streuli and Meng (2019).
Flow
The endothelial layer of blood vessels is constantly exposed
to the blood stream and hemodynamic forces, such as shear
stress and tangential forces (Song and Munn, 2011). Cells
respond to these forces by changing their morphology and gene
expression (Wragg et al., 2014), with shear stress inhibiting
EC proliferation and limiting sprouting to low flow regions
(e.g., tumor microenvironment and ischemia) (Song and Munn,
2011; Tun et al., 2019). Song and Munn (2011) developed a
perfused microfluidic device and reported a reduction in VEGF-
induced sprouting under physiological shear stress. Despite
several microfluidic solutions developed to study angiogenesis
(Yeon et al., 2012; Zheng et al., 2012; Motherwell et al., 2019), the
current focus is limited to the evaluation of the platforms with
limited application to molecular or biological studies.
The application of flow to enhance the maturation of blood
vessels within TE scaffolds is still not fully developed. For
example, dynamic flow and enhanced shear stress applied to
endothelial cell seeded poly-(L-lactic acid) scaffold enhanced
EC migration (Koo et al., 2014). Indeed, the flow derived Wall
Shear Stress (WSS) affects the interaction between ECs (EC-
EC), as well as between EC and smooth muscle cells (EC-
SMC), in TE constructs, consequently affecting vessel maturation
(Shav et al., 2014).
The next challenge for TE is to integrate this newly acquired
knowledge to promote the formation of functional blood vessels
in engineered scaffolds.
Hypoxia
Low oxygen concentration is a potent regulator of angiogenesis,
driving sprouting of ECs toward the deficient tissue (Pugh
and Ratcliffe, 2003; Ziyad and Iruela-Arispe, 2011; Viallard and
Larrivée, 2017; Petrova et al., 2018) through hypoxia inducible
factor-dependent increase of VEGF transcription (Liao and
Johnson, 2007; Oladipupo et al., 2011). Recreating a hypoxic
environment has been revealed to be useful for therapeutic
angiogenesis in bone TE both in vitro and in vivo (Wu et al.,
2012; Deng et al., 2019). Wu et al. (2012) developed a porous
cobalt-containing mesopore-bioglass scaffold able to release ionic
Co2+, inducing a hypoxic-mediated response in human bone
marrow stromal cells. Similarly, Deng et al. (2019) used a
cobalt-doped bioactive borosilicate glass scaffold in vivo, showing
improved vascularization and regeneration of bone tissue after
implantation in rats with a calvarial defect.
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INTERACTIONS WITH OTHER CELLS
Endothelial cells are the primary cell type driving angiogenesis,
however, their use alone is often not sufficient to recapitulate
physiological angiogenesis in TE applications (Costa-Almeida
et al., 2014). Angiogenesis in vivo involves complex signaling
pathways between ECs and other associated supportive cells,
such as pericytes and macrophages (Ribatti and Crivellato, 2009;
Cathery et al., 2018). In order to mimic this natural process,
researchers have used combinations of proangiogenic cells to
promote the vascularization of scaffolds. Here, we discuss the cell
types which have shown potential for this purpose.
Heterogeneity of Endothelial Cells
All vascular EC originate in the embryonic mesoderm (Dyer
and Patterson, 2010), however, they display remarkable organ-
specific characteristics and genetic programming, leading
to specialization in morphology, such as fenestrations, and
functionality, such as cell-cell interaction and permeability
(Chi et al., 2003; Nolan et al., 2013). EC differentiation relies
on both epigenetic mechanisms and the interaction with the
microenvironment, determining the existence of different sub-
types of EC even within the same vascular bed (Kusumbe et al.,
2014; Ramasamy, 2017; Barry et al., 2019). For example, two sub-
populations of EC have been characterized in the murine skeletal
system; the H type, which are responsible for angiogenesis,
and the L type, which form the sinusoidal capillaries in bones
(Kusumbe et al., 2014). Interestingly, when EC are extracted
from their natural environment and cultured in vitro, they can
lose their specialized gene expression signature (Lacorre et al.,
2004). One meaningful example is the reduced ability of brain
ECs to independently recapitulate the impenetrability of the
blood-brain barrier in culture (Janzer and Raff, 1987; Dyer and
Patterson, 2010). This heterogeneity must be considered when
selecting the EC population to be employed for organ-specific
TE applications.
Perivascular/Mural Cells
Perivascular cells, such as pericytes, vascular smooth muscle cells
(VSMCs), mesenchymal stromal cells (MSCs) and fibroblasts
reside within the vascular niche and play an integral role in
blood vessel development (Costa-Almeida et al., 2014). Pericytes
contribute to angiogenesis and vessel maturation through direct
contact with ECs and secretion of GF, MMPs, and ECM
deposition (Cathery et al., 2018). Fibroblasts secrete a similar
array of potent angiogenic factors and MMPs, and are also the
primary source of ECM, whilst VSMC play a similar supportive
role in larger blood vessels (Costa-Almeida et al., 2014). For
this reason perivascular cells have become the preferred choice
to support vascularization in TE (Avolio et al., 2017). For
example, Wang et al. (2017a) demonstrated that the addition of
pericytes to a co-culture system seeded into a calcium phosphate
cement scaffold increased vessel density by over 65% after
12 weeks. Sathy et al. (2015) also reported promising results
following incorporation of pericytes into multi-layered scaffolds
designed for tissue engineered bone. The authors were able
to produce vascularized bone constructs of up to 400 µm
in thickness. Recently Liu et al. (2019) utilized a co-culture
system of ECs and bone marrow MSCs encapsulated in Gel-
MA microspheres to investigate whether MSCs could mimic
the role of pericytes and increase angiogenesis. They discovered
that the MSCs differentiated toward a pericyte phenotype,
and subsequently significantly enhanced vascularization and
integration with host tissue in vivo (Liu et al., 2019). Although
pericyte-like cells seem like the popular choice due to their
prominent role in angiogenesis, some research groups have
also reported success with other perivascular cells. Wang et al.
(2012) observed rapid vascularization of tissue engineered grafts
in vivo using a scaffold seeded with ECs and VSMCs. Likewise,
Guerreiro et al. (2014) demonstrated that fibroblasts immobilized
in alginate microspheres support assembly of capillary-like
structures. Overall, these findings demonstrate the suitability of
perivascular cells for angiogenesis in TE. Their easy isolation
combined with their close association with blood vessels make
them an ideal candidate for further studies.
Macrophages
Immune cells, such as macrophages, are closely connected with
angiogenesis. Macrophage phenotypes vary along a spectrum
from a pro-inflammatory M1 state to a pro-healing M2
state (Moore and West, 2019), resulting in certain subsets of
macrophages triggering inflammation, and others tissue healing,
after injury. Pro-healing macrophages act by secreting pro-
angiogenic factors that promote endothelial proliferation and
migration, resulting in neovascularization (Ribatti and Crivellato,
2009). Moreover, macrophages play a key role in vascular
anastomosis, which further highlights their potential for use
FIGURE 1 | Schematic representation of the factors involved in the
development and regulation of blood vessels in vivo, and their relative
contribution as represented by the fraction occupied in the pie chart.
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in the vascularization of tissue engineered constructs (Fantin
et al., 2010). In fact, Spiller et al. (2014) proposed that a
combination of activated macrophage phenotypes could be used
to control angiogenesis in TE strategies. By modifying scaffold
properties, they were able to direct macrophage phenotype
transitions and increase vascularization. Similarly, Barthes
et al. (2018) incorporated phenotype-restricted macrophages
into a 3D gelatin hydrogel scaffold. They reported that the
presence of macrophages not only amplified the angiogenic
microenvironment, but also gave rise to highly organized
sprouting that resembled capillary-like structures. Additionally,
Moore et al. (2018) used a bioactive PEG-based hydrogel
to study the role of various macrophage phenotypes in
vessel development. The authors discovered that whereas some
phenotypes enhanced tube formation in tissue engineered
scaffolds, others had an antagonistic effect. This demonstrates
that whilst macrophages have shown potential for tissue
vascularization strategies, caution must be applied to avoid
adverse effects.
Neural Cells
Similarities between the nervous and vascular systems have been
well studied. These systems align with each other throughout the
body and develop highly branched networks through common
cellular and molecular principles (Eichmann and Thomas, 2013).
In fact, the specialized ECs termed “tip cells,” which lead the
vascular sprouting process, express receptors for axon guidance
molecules. Loss of function of these receptors results in defective
vessel formation, showing their importance for angiogenesis
(Eichmann and Thomas, 2013). Himmels et al. (2017) recently
described a neuro-vascular signaling mechanism responsible for
guiding vessel development. The authors demonstrated that
motor neurons regulate blood vessel patterning via an autocrine
mechanism involving VEGF secretion and expression of a VEGF
trapping receptor, soluble fms-like tyrosine kinase-1 (sFlt1)
(Himmels et al., 2017). Furthermore, Emanueli et al. (2003)
described the intricate role neurotrophins play in vascularization.
In a mouse model of limb ischemia, overexpression of
neurotrophin-3 (NT-3) was shown to increase capillary and
arteriolar density (Cristofaro et al., 2010). Similarly, in vitro
studies showed NT-3 stimulated endothelial network formation,
increasing the number and diameter of functional vessels. This
research further highlights the potential of neural derived cells
and GF for vascularization strategies.
Within a TE context, Rauch et al. (2009) showed that
the addition of neural progenitor cells to composite polymer
scaffold seeded with ECs, resulted in a two-fold increase in
functional vessels. Ford et al. (2006) demonstrated similar
results with neural progenitor-endothelial cocultures seeded in
microporous scaffolds, producing a functional microcirculation
in vivo. Although there are limited studies to date, these
discoveries suggest that integration of neural-derived cells into
engineered tissue constructs could help guide angiogenesis and
vascular development.
CONCLUSION AND PERSPECTIVES
This review provides a summary of the most advanced
bioengineering solutions developed to mimic the natural
development of blood vessels within TE constructs, and
the complex network of interacting factors regulating this
phenomenon in vivo (Figure 1). It is indisputable that
scientists are increasingly more aware of the complexities of
the phenomenon and that the landscape has progressively
become more articulated. However, we are still in the initial
phases of this process and the development of more complex
scaffolds, encompassing several of the characteristics described
above, is a desirable avenue for future studies. Undoubtedly,
the development of deep-learning algorithms through machine
learning (Park et al., 2018; Nguyen et al., 2019) can potentially
open a new era for the multiparametric acquisition of data,
offering a window on the resolution of TE vascularization, as
nature intended.
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